Artificial  ||| S:0 E:11 ||| JJ
insemination  ||| S:11 E:24 ||| JJ
technology  ||| S:24 E:35 ||| NN
for  ||| S:35 E:39 ||| IN
the  ||| S:39 E:43 ||| DT
emu--improving  ||| S:43 E:58 ||| JJ
sperm  ||| S:58 E:64 ||| JJ
survival  ||| S:64 E:73 ||| NN
For  ||| S:73 E:77 ||| IN
the  ||| S:77 E:81 ||| DT
emu ||| S:81 E:84 ||| NN
,  ||| S:84 E:86 ||| ,
where  ||| S:86 E:92 ||| WRB
monogamous  ||| S:92 E:103 ||| JJ
mating  ||| S:103 E:110 ||| NN
is  ||| S:110 E:113 ||| VBZ
normal ||| S:113 E:119 ||| JJ
,  ||| S:119 E:121 ||| ,
artificial  ||| S:121 E:132 ||| JJ
insemination  ||| S:132 E:145 ||| NNS
( ||| S:145 E:146 ||| -LRB-
AI ||| S:146 E:148 ||| NNP
)  ||| S:148 E:150 ||| -RRB-
promises  ||| S:150 E:159 ||| VBZ
much  ||| S:159 E:164 ||| RB
faster  ||| S:164 E:171 ||| RBR
genetic  ||| S:171 E:179 ||| JJ
improvement  ||| S:179 E:191 ||| NN
and  ||| S:191 E:195 ||| CC
a  ||| S:195 E:197 ||| DT
considerable  ||| S:197 E:210 ||| JJ
reduction  ||| S:210 E:220 ||| NN
in  ||| S:220 E:223 ||| IN
production  ||| S:223 E:234 ||| NN
costs  ||| S:234 E:240 ||| NNS
by  ||| S:240 E:243 ||| IN
reducing  ||| S:243 E:252 ||| VBG
the  ||| S:252 E:256 ||| DT
number  ||| S:256 E:263 ||| NN
of  ||| S:263 E:266 ||| IN
male  ||| S:266 E:271 ||| JJ
birds  ||| S:271 E:277 ||| NNS
needed  ||| S:277 E:284 ||| VBN
for  ||| S:284 E:288 ||| IN
mating ||| S:288 E:294 ||| NN
.  ||| S:294 E:296 ||| .
Semen  ||| S:296 E:302 ||| JJ
collection  ||| S:302 E:313 ||| NN
is  ||| S:313 E:316 ||| VBZ
now  ||| S:316 E:320 ||| RB
a  ||| S:320 E:322 ||| DT
routine  ||| S:322 E:330 ||| JJ
procedure  ||| S:330 E:340 ||| NN
so  ||| S:340 E:343 ||| IN
the  ||| S:343 E:347 ||| DT
next  ||| S:347 E:352 ||| JJ
step  ||| S:352 E:357 ||| NN
is  ||| S:357 E:360 ||| VBZ
to  ||| S:360 E:363 ||| TO
develop  ||| S:363 E:371 ||| VB
successful  ||| S:371 E:382 ||| JJ
protocols  ||| S:382 E:392 ||| NNS
for  ||| S:392 E:396 ||| IN
sperm  ||| S:396 E:402 ||| JJ
storage ||| S:402 E:409 ||| NN
.  ||| S:409 E:411 ||| .
In  ||| S:411 E:414 ||| IN
this  ||| S:414 E:419 ||| DT
paper ||| S:419 E:424 ||| NN
,  ||| S:424 E:426 ||| ,
we  ||| S:426 E:429 ||| PRP
briefly  ||| S:429 E:437 ||| RB
overview  ||| S:437 E:446 ||| VB
our  ||| S:446 E:450 ||| PRP$
recent  ||| S:450 E:457 ||| JJ
progress  ||| S:457 E:466 ||| NN
on  ||| S:466 E:469 ||| IN
the  ||| S:469 E:473 ||| DT
development  ||| S:473 E:485 ||| NN
of  ||| S:485 E:488 ||| IN
protocols  ||| S:488 E:498 ||| NNS
for  ||| S:498 E:502 ||| IN
liquid  ||| S:502 E:509 ||| JJ
storage  ||| S:509 E:517 ||| NN
and  ||| S:517 E:521 ||| CC
cryopreservation  ||| S:521 E:538 ||| NN
of  ||| S:538 E:541 ||| IN
emu  ||| S:541 E:545 ||| JJ
spermatozoa ||| S:545 E:556 ||| NN
.  ||| S:556 E:558 ||| .
We  ||| S:558 E:561 ||| PRP
have  ||| S:561 E:566 ||| VBP
shown  ||| S:566 E:572 ||| VBN
that  ||| S:572 E:577 ||| IN
emu  ||| S:577 E:581 ||| JJ
semen  ||| S:581 E:587 ||| NN
can  ||| S:587 E:591 ||| MD
be  ||| S:591 E:594 ||| VB
stored  ||| S:594 E:601 ||| VBN
at  ||| S:601 E:604 ||| IN
10  ||| S:604 E:607 ||| CD
Â°C  ||| S:607 E:610 ||| CD
for  ||| S:610 E:614 ||| IN
up  ||| S:614 E:617 ||| RB
to  ||| S:617 E:620 ||| TO
48  ||| S:620 E:623 ||| CD
h  ||| S:623 E:625 ||| NN
with  ||| S:625 E:630 ||| IN
a  ||| S:630 E:632 ||| DT
minimal  ||| S:632 E:640 ||| JJ
loss  ||| S:640 E:645 ||| NN
of  ||| S:645 E:648 ||| IN
viability ||| S:648 E:657 ||| NN
,  ||| S:657 E:659 ||| ,
and  ||| S:659 E:663 ||| CC
that  ||| S:663 E:668 ||| DT
cryopreservation  ||| S:668 E:685 ||| NN
with  ||| S:685 E:690 ||| IN
dimethylacetamide  ||| S:690 E:708 ||| NNS
( ||| S:708 E:709 ||| -LRB-
DMA ||| S:709 E:712 ||| NNP
)  ||| S:712 E:714 ||| -RRB-
as  ||| S:714 E:717 ||| IN
a  ||| S:717 E:719 ||| DT
cryoprotectant  ||| S:719 E:734 ||| NN
is  ||| S:734 E:737 ||| VBZ
feasible  ||| S:737 E:746 ||| VBN
because  ||| S:746 E:754 ||| IN
we  ||| S:754 E:757 ||| PRP
have  ||| S:757 E:762 ||| VBP
observed  ||| S:762 E:771 ||| VBN
no  ||| S:771 E:774 ||| DT
adverse  ||| S:774 E:782 ||| JJ
effects  ||| S:782 E:790 ||| NNS
of  ||| S:790 E:793 ||| IN
this  ||| S:793 E:798 ||| DT
cryoprotectant  ||| S:798 E:813 ||| NN
on  ||| S:813 E:816 ||| IN
the  ||| S:816 E:820 ||| DT
emu  ||| S:820 E:824 ||| JJ
sperm  ||| S:824 E:830 ||| JJ
membrane  ||| S:830 E:839 ||| JJ
integrity ||| S:839 E:848 ||| NN
,  ||| S:848 E:850 ||| ,
morphology  ||| S:850 E:861 ||| NN
and  ||| S:861 E:865 ||| CC
motility ||| S:865 E:873 ||| NN
.  ||| S:873 E:875 ||| .
We  ||| S:875 E:878 ||| PRP
now  ||| S:878 E:882 ||| RB
need  ||| S:882 E:887 ||| VBP
to  ||| S:887 E:890 ||| TO
establish  ||| S:890 E:900 ||| VB
the  ||| S:900 E:904 ||| DT
predictability  ||| S:904 E:919 ||| NN
of  ||| S:919 E:922 ||| IN
the  ||| S:922 E:926 ||| DT
various  ||| S:926 E:934 ||| JJ
tests  ||| S:934 E:940 ||| NNS
in  ||| S:940 E:943 ||| IN
vivo ||| S:943 E:947 ||| NN
,  ||| S:947 E:949 ||| ,
but  ||| S:949 E:953 ||| CC
the  ||| S:953 E:957 ||| DT
proportions  ||| S:957 E:969 ||| NNS
of  ||| S:969 E:972 ||| IN
live  ||| S:972 E:977 ||| JJ
normal  ||| S:977 E:984 ||| JJ
and  ||| S:984 E:988 ||| CC
motile  ||| S:988 E:995 ||| JJ
sperm  ||| S:995 E:1001 ||| NN
with  ||| S:1001 E:1006 ||| IN
good  ||| S:1006 E:1011 ||| JJ
egg  ||| S:1011 E:1015 ||| NN
membrane  ||| S:1015 E:1024 ||| NNS
penetration  ||| S:1024 E:1036 ||| VBP
potential  ||| S:1036 E:1046 ||| JJ
suggest  ||| S:1046 E:1054 ||| NN
that  ||| S:1054 E:1059 ||| IN
acceptable  ||| S:1059 E:1070 ||| JJ
numbers  ||| S:1070 E:1078 ||| NNS
of  ||| S:1078 E:1081 ||| IN
competent  ||| S:1081 E:1091 ||| JJ
sperm  ||| S:1091 E:1097 ||| NNS
are  ||| S:1097 E:1101 ||| VBP
preserved  ||| S:1101 E:1111 ||| VBN
and  ||| S:1111 E:1115 ||| CC
that  ||| S:1115 E:1120 ||| IN
this  ||| S:1120 E:1125 ||| DT
will  ||| S:1125 E:1130 ||| MD
be  ||| S:1130 E:1133 ||| VB
sufficient  ||| S:1133 E:1144 ||| JJ
for  ||| S:1144 E:1148 ||| IN
AI ||| S:1148 E:1150 ||| NNP
.  ||| S:1150 E:1152 ||| .
